Wela Strategies’s GE HealthCare GEHC Stock Holding History

Wela Strategies’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,650	Closed	-$345K	–	63
2024 Q4	$345K	Buy	+5,650	New	+$480K	0.15%	45

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wela Strategies's GEHC Position: Q1 2025 in Review

Wela Strategies sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 5,650 shares — an estimated $345K sold.

Wela Strategies first reported a position in GEHC in Q4 2024 and held it in 1 quarter. The position peaked at $345K in Q4 2024. 1,367 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Wela Strategies reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Wela Strategies sold 5,650 GE HealthCare shares in Q1 2025, an estimated $345K.
Wela Strategies first reported a position in GE HealthCare in Q4 2024 and held it in 1 quarter.
Wela Strategies's GE HealthCare position peaked at $345K in Q4 2024.
1,367 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Wela Strategies's 13F filing for Q1 2025, filed 14 Apr 2025.